iBRIDGE CONVERSATION


Archive for the 'iBridge Network' Category

New Privacy Policy and Terms of Use

Thursday, July 3rd, 2008

Per an email sent to iBridge Network members today…

We’re writing to let you know that our privacy policy and terms of use have been updated. We do not expect to send you many emails of this nature, but sometimes it is necessary.

In addition to this news, we also have some other exciting updates and developments. The iBridge Network now has over 3,000 innovations and research objects posted from 38 campuses located across the United States. With visitors from over 5,200 cities, representing over 150 countries, the Network is moving forward boundlessly.

Innovations listed on the site are in a range of subject areas that vary from cell lines to software to nanotechnology to agricultural substances.

What are you interested in? Perhaps…

  • Needle-Free Liquid Jet Injector for Drug and Vaccine Delivery - Most vaccines and protein therapeutics are currently delivered using needles and syringes. Despite their common use, needle-based methods have several limitations such as needle phobia, accidental needle sticks and re-use of needles and syringes in developing countries leading to a large number of HIV and HBV cases.
  • Hydrogen Generation from Solar Energy - The idea of splitting water with sunlight is quite old, but the current efficiency of such systems is only 7%-12%. This invention incorporates photovoltaic cells (PV) and micro-chemical reactors to create an integrated device that utilizes light energy to convert water into hydrogen at a more efficient rate than current technologies. The device is compact, scalable, and can be manufactured using conventional integrated circuit manufacturing technology.
  • Improved contrast agent for MRI using fluorinated nanoparticles - Washington University is actively seeking partners to further develop an innovative new contrast agent for magnetic resonance imaging that could revolutionize diagnostic imaging. The agent, which uses fluorinated nanoparticles, enhances the use of MRI for diagnosing cardiovascular disease.
  • Test Offers Early Detection of Melanomas and Other Cancers - A new blood and tissue test can detect metastatic cancer at an early and treatable stage. This noninvasive test detects over 95% of advanced melanomas and is up to 1,000-fold more sensitive than other testing methods, enabling it to detect very low levels of cancer.

Keep visiting the iBridge Web site or subscribe to find out about the new innovations posted to the site regularly.

Who knows what you’ll find?

Best,

The iBridge Network Team

P.S. Watch for the upcoming inaugural issue of the iBridge Network Newsletter. In this regular publication, you will enjoy learning more about what the Network is doing as well as the work of the Kauffman Foundation in the area of advancing innovation and entrepreneurism.


Q&A: The Kauffman Foundation & Knowledge Transfer

Thursday, May 8th, 2008

Recently, we have received questions about what some believe are controversial statements from the Kauffman Foundation about its interest in expanding how universities pursue their innovation and commercialization missions. The iBridgeSM Network team thought it would be helpful to talk with Lesa Mitchell, the Foundation’s vice president of Advancing Innovation, about the Foundation’s positions. So, I, director of the iBridge Network, interviewed Lesa.

We hope the following information helps to clarify things, and we welcome your questions and observations.

Laura: Some people perceive that the Kauffman Foundation has
been negative about Technology Transfer Offices (TTOs) at universities. Does the Kauffman Foundation view TTOs negatively?

Lesa: Not at all. In fact, representatives from TTOs helped shape the Foundation’s interest in university innovation when we were researching the area a few years ago and helped us identify ways in which the Kauffman Foundation could help universities, and their TTOs more specifically, do more with their research and innovations. We have worked closely with TTOs, including Kauffman Campuses, the iBridge Network, and the Association of University Technology Managers (AUTM), to identify opportunities for universities, TTOs, and the Foundation to forward the work of advancing university innovation to make it more efficient and have an even greater impact.

For instance, the Kauffman Foundation funded AUTM for three years to encourage projects like a strategic plan, the Better World Project, and New Metrics Project. AUTM has done a great job in all of these areas. These AUTM projects seek to shine light on and encourage broader views of the outcomes of university innovation beyond a narrow focus on licensing income. Our support of these AUTM initiatives reflects the Foundation’s interest in having university research and innovation – and TTOs for that matter – valued for more than just licensing revenue.

Laura: Doesn’t the Foundation’s interest in this expanded view of technology transfer undermine the work that TTOs are doing now?

Lesa: Actually, we hope that our efforts will enhance the work of TTOs. The vast majority of the patent-licensing offices are under-resourced and under-staffed. Most also are struggling to support faculty in more ways than the traditional patent-license model, which is the model that has been thrust upon them. In reality, there are numerous models and strategies that universities should consider to maximize the usefulness of research and innovations that also advance research, grow the U.S. economy, and advance human welfare.

If our efforts with university administrations are successful and help them think outside of traditional methods, TTOs may gain more resources and staffing. TTOs also may be able to truly focus on licensing income because distractions inherent in other strategies for advancing useful, but non-revenue potential research and innovations, will be handled in other ways. Both results might be ideal and generally better than the status quo.

Laura: In fact, didn’t the iBridge Network and Web site evolve because of feedback from TTOs who wanted alternative pathways to make their university’s research and innovations more readily accessible and available?

Lesa: Absolutely. Ultimately, we believe that the iBridge Network will enable universities to move higher volumes of innovation outside of university walls to those seeking innovation in an expedited manner. With additional resources, like the iBridge Network, TTOs can do more and be more effective.

Laura: Why does the Kauffman Foundation challenge TTOs?

Lesa: The Kauffman Foundation is not intending to criticize TTOs. As mentioned a moment ago, because TTOs are under-staffed and under-resourced, they face enormous challenges and they do well handling them. What we are critical of, however, are university policies, practices, and strategies that presume that a “one-size-fits-all” approach will work or that what worked at one institution will automatically work at another or that licensing revenue is all that matters.

The Foundation aims to raise the awareness of university boards and leaders who are responsible for decisions regarding organizational structure and practices that may or may not support the goals of broadly enabling university innovation and commercialization. Our intention is to stress the importance of having organizational structures and practices that support providing multiple resources to assist in expanding the reach of innovation and outcomes –some of which will be tied to formal IP, but most will not.

Those universities who engage in technology transfer most successfully have demonstrated these insights and taught us about them. The net result is that knowledge dissemination happens every day at these institutions, and the rest of us have to work harder from the ground up and top down to reach that degree of success.

Laura: Any last thoughts based on the Kauffman Foundation’s research?

Lesa: We have been studying the U.S. environment for advancing innovation compared to the environment abroad. In the U.S., universities have many advantages, including endowments, federal research dollars, and a high level of philanthropy that are relatively non-existent in the rest of the world. These are significant advantages that should produce a substantially higher level of innovation output. We must ensure that the U.S. uses its current innovation, commercialization and entrepreneurship advantages to maintain a high level of global competitiveness and grow our economy, which in the process also will advance human welfare.

It seems that models of open innovation are prevalent at leading universities outside of the U.S., and these institutions are aggressively pursuing university - industry collaborations. The leaders of our US universities need to understand this threat in the context of our global economy and educational environment so they can begin to focus on strategies around knowledge transfer that meet the various needs of research and industry. For instance, Michael Crow and his team at ASU are developing innovation strategies specifically with this in mind, as are the University of Washington engineering school and many others, including some of our Kauffman CampusSM universities. Of course, what I’ve just characterized as a “threat,” actually may really be an opportunity for additional outlets for innovation initiating from U.S. universities.

In the interests of disclosure, the Foundation is the primary funder
of the Kauffman Innovation Network, Inc. and its iBridge Network initiative.


The University-Industry Demonstration Partnership

Tuesday, April 8th, 2008

The UIDP is coming, the UIDP is coming! We are so excited for this meeting to be held at the Ewing Marion Kauffman Foundation from April 9-10. It is the first conference of its kind; focusing on open innovation and open collaboration between universities and industries. We are thrilled to see real models in place and learn how it’s done! The iBridge Network will also have a booth at the conference, so we can share how we make university developed research easy to access for anyone with access to the internet.


Life Sciences Venture Forum

Wednesday, March 12th, 2008

Interested in early stage innovation and entrepreneurship? We thought so! The Larta Institute is hosting the 14th Life Sciences Venture Forum on May 30 at the Santa Clara Convention Center.

The Venture Forum is the largest - and longest running - showcase of early stage innovation and entrepreneurship. We hear that it is the must-attend event for those seeking access to the best quality deals from around the world. As Larta Institute’s landmark annual investment and partnering event, it is expected to showcase the most promising seed & early stage life science opportunities.

As one of the iBridge Network’s members, we know how robust Larta’s pipeline is, ranging from research funded by the National Institutes of Health to some of the most promising university spinouts from across the US. At the Venture Forum, the companies are carefully selected by a panel of leading investors and subject matter experts to ensure that each presenting company offers a solid and profitable business opportunity.

Sound good? You can receive a 30% discount off the registration fee, until May 16, 2008. Register now at http://theventureforum.com/registration.asp and use coupon code IBVF08 to take advantage of this special offer.


DEMO 08

Thursday, February 7th, 2008

I just returned from beautiful, sunny Palm Springs, CA and DEMO 08. It’s been a year since we re-launched the iBridge Network there, and it was great to be back! As part of the Kauffman Foundation’s sponsorship, we had a booth and a panel of faculty. Dr. Steven Barlow, from the University of Kansas and Dr. Yannis Papakonstantinou, from the University of California, San Diego, gave their insights on the research and turning ideas into innovations. In addition to our outstanding panel, I want to give many congratulations to all the DEMO God winners for 2008. There were so many outstanding innovations and products, it was really amazing to see all of them in action during the demonstrations. I loved the Pulse Smartpen and Livescribe Paper, it is a computer in a pen that records and links audio to the paper! I know pretty amazing, if only I had that in college. The other product that really caught my eye was Flypaper. Flypaper allows the regular Joe to create multimedia communication without having to figure out Flash. I can’t wait until they are all available to the public, so I can put them to good use!

We also had many questions for the iBridge Network, and many people who have heard about us through the grapevine. We were able to demonstrate the functionality of the Web site and show many of the exciting innovations that you all have posted.


Welcome to iBridge Network…

Friday, December 7th, 2007

Lehigh University & Lankenau Institute for Medical Research!

We are excited to welcome both institutions to the Network! Thank you to Yatin S. Karpe and Erin E. DeStefano for your help in this process! As you can see the the iBridge Network is growing, and with more institutions in the pipeline, please stay tuned for further news…

As we look forward to 2008, there have been a few other announcements we’d like to finally make public. Katie Petersen recently joined the team and will be working to help institutions post their innovations in the network. She is an excellent addition to the iBridge family, and you may have met her over the phone already! I am our other addition. I recently joined the team and will be writing for the iBridge Conversation. As you can tell, we are thrilled to be filling out our incredible team!

It is a very exciting time for the iBridge Network so thank you to the institutions and researchers who have helped get us to this point! We are working hard to help spread your discoveries and innovations as far as possible!

Emile Petrone


Science Commons in Popular Science!

Friday, July 20th, 2007

Congratulations to our friends over at Science Commons who have been written up in Popular Science magazine this week! I love hearing John Wilbanks talk about why it should be easier to share and find scientific information even if you aren’t immersed in that particular field. If you have never heard or read anything from him, I would suggest for you to read the article.

As you may know, the iBridge Network is working with Science Commons on their Material Transfer Agreement project which provides a wide array of standardized licenses including the Uniform Biological Materials Transfer Agreement (UBMTA) and the Simple Letter Agreement (SLA) in addition to several standard ones developed by Science Commons. Standardized licensing of research materials happens today, though it may not be as common as one would think. We are expecting with the additional of several other standardized licenses, and the ease of specifying them (through Science Commons tools), and ease of attaching these licenses to research descriptions in the iBridge Network will help fuel use of standardized agreements for more situations.

We are expecting to have standardized licensing up on our site by the end of the summer and already have a couple of our university members who are planning to participate as early adopters! We’ll keep you posted!


May-June ‘07 iBridge Network Information Sessions Set

Thursday, May 17th, 2007

We’ve just lined up our next batch of Information Sessions for those interested in learning more about iBridge Network and how it can help universities market their innovations and inventions.

These sessions are held via WebEx-based conference calls, and each last about one hour. Laura Paglione, iBridge Network director, leads these sessions.

Here is our schedule of Information Sessions for the rest of May and June 2007:

  • Thursday, May 31, 10:00 AM Central
  • Wednesday, June 13, 3:00 PM Central
  • Friday, June 29, 10:00 AM Central

Signing up is easy. Just click here and select the Information Session date that works for you. Once you do this, you’ll receive a confirmation email with all of the relevant information and with easy instructions to log into the session.

Any questions, just send us an email at info@iBridgeNetwork.org or call 1-800-573-5136.


U.S. Universities Continue to Drive Biotech Innovation

Friday, May 11th, 2007

At the Bio International Convention 2007, which took place earlier this week in Boston, the iBridge Network (along with the Kauffman Foundation) made a strong presence before the assemblage. If you’ve ever had a chance to attend this conference, you know of its unique brand of energy and all out global marketing competition (which means you get to bring home a bagful of conference swag for the kids).

Along this line, one major study, released on Monday at the conference, showed good news for university-based life sciences research. (Here’s an article on this report in The Financial Times.)

The study, conducted by Marks and Clerk, a United Kingdom-based law firm, found that among the world’s top twenty patent filing entities, academia beats out corporate by 51 percent in regard to patent production between 2002-2006.

The report also showed the world’s top patent filers, over the last five years, are the Japan Science and Technology Agency, the University of California, the U.S. government, Genentech, Inc., and the University of Texas. And note that the top twenty list is comprised mostly of U.S. universities. In addition, The Financial Times notes the study found the most influential biotech-related patents (based on their citation frequency) are all held by U.S. universities (with MIT/Harvard in the lead).

 


DoD’s New DaVenCi Code

Wednesday, May 9th, 2007

Would you believe the U.S. Department of Defense (DoD) is drinking more of the Silicon Valley Kool Aid? That is, a new DoD program, called the Defense Venture Catalyst Initiative (or DaVenCi for short) is working to link up its personnel with venture capitalists who recommend for military use new innovations and technologies being developed by startups around the country.

The point is that DoD may be evolving out of old-style procurement and speeding up dramatically its identification and acquisition of technologies it needs for national defense. The New York Times earlier this week ran a piece on how all of this is coming about.

And for more, consider Tech Transfer eNews’s (subscription required) angle on this topic in its recent issue, which is that universities have an equally vital role to play (along with VCs) with regard to programs like DaVenCi. “The initiative — and the article — ignore the potential role of university tech transfer in that effort,” according to eNews. And it adds: “The focus on VC’s shouldn’t stop determined tech transfer managers from marketing their IP.”